New antibody drug tested against severe COVID-19 in hospital patients
Disease control
Terminated
This study tested an experimental antibody drug called SCTA01 in adults hospitalized with severe COVID-19. Participants received either the drug or a placebo to see if it helped them recover faster. The trial was stopped early, so results are limited.
Phase: PHASE2, PHASE3 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC